Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2017 | A new era in CLL

Federico Caligaris-Cappio • 12 May 2017
iwCLL 2017
Chronic Lymphocytic Leukemia

Federico Caligaris-Cappio, MD from Vita-Salute San Raffaele University, Milan, Italy discusses with excitement the advances in chronic lymphocytic leukemia (CLL) at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY. Prof. Caligaris-Cappio describes how he is looking forward to seeing how scientific developments in CLL will be translated into clinical application. He specifically mentions how progress in detecting molecular and genetic abnormalities will introduce an era of personalised medicine, offering treatment that is specifically tailored to the individual patient.

More from Federico Caligaris-Cappio

5:14
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al. • 29 Feb 2016
4:30
How the removal of macrophages from tissue can stop or slow down the progression of CLL
Federico Caligaris-Cappio • 16 Sep 2016
2:21
Key questions to be discussed at iwCLL 2017: cancer genetics, immunology and categorizing patients
Federico Caligaris-Cappio • 16 Sep 2016
4:30
The origin and work of the International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
Federico Caligaris-Cappio • 16 Sep 2016

Related Videos

3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
Richter’s transformation: biology & ongoing trials in the field
Carsten Niemann et al. • 25 Mar 2024
The content of VJHemOnc is intended for healthcare professionals